Fig 1.
Decision tree.
Table 1.
Clinical pathways.
Table 2.
Probability inputs.
Table 3.
Utility and length of stay (LoS) inputs.
Table 4.
Cost inputs.
Table 5.
Cost-utility analysis of Dexamethasone against No Dexamethasone.
Table 6.
Cost-utility analysis of updated clinical practice against previous clinical practice.
Table 7.
Cost-utility analysis of faster recruitment to the RECOVERY trial.
Fig 2.
Cost-effectiveness plane.
Fig 3.
Cost-effectiveness acceptability curve (CEAC).